Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Moleculin Biotech ( (MBRX) ) has provided an announcement.
Moleculin Biotech, Inc. announced that it will use a new corporate presentation available on its website, which is shared as part of a current report but not filed under the Securities Exchange Act. This move highlights the company’s efforts to engage investors without altering its formal filings, offering insights into its strategic developments.
See more insights into MBRX stock on TipRanks’ Stock Analysis page.
